Welcome Center  |   Log In  |   Register  |   Follow Us  Facebook  Twitter Google Plus

More in Pulmonary Medicine

Reuters Health • The Doctor's Channel Daily Newscast

Diagnostic criteria for acute lung injury may be too stringent

NEW YORK (Reuters Health) – Given that arterial lines are used less frequently in pediatric ICUs these days, the criteria for diagnosis of acute lung injury are less often available, making it extremely difficult to conduct randomized controlled trials...

Reuters Health • The Doctor's Channel Daily Newscast

Nadroparin reduces clots risk during treatment for advanced cancer

NEW YORK (Reuters Health) – Nadroparin, a low-molecular-weight heparin, reduces the incidence of thromboembolic events in ambulatory patients receiving chemotherapy for metastatic or locally advanced solid cancers, an Italian research team reports. ...

Reuters Health • The Doctor's Channel Daily Newscast

Gefitinib superior to carboplatin-paclitaxel for some with lung adenocarcinoma

NEW YORK (Reuters Health) – The tyrosine kinase inhibitor gefitinib is more effective than standard therapy with carboplatin-paclitaxel for lung adenocarcinomas with mutations in the epidermal growth factor receptor gene (EGFR). Furthermore,...